Zimmer Biomet Holdings, Inc.

The current price of ZBH is $106.06 — it has decreased by 3.71% since the previous close. Data as of Nov 5, 2026.

ZBH is up 10.66% over the past week, up 15.82% over the past month and up 21.14% over the past year. The price is above its 200-day moving average of $91.84.

Analysts' average 12-month price target for ZBH is $108.22, which implies 2.04% upside from the current price. Individual estimates range from $93.00 to $125.00.

Of the 27 analysts covering Zimmer Biomet Holdings, Inc., 2 rate it a strong buy, 6 rate it a buy and 19 rate it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.

Zimmer Biomet Holdings, Inc. has a market capitalization of $20.23B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Zimmer Biomet Holdings, Inc. posted earnings of $1.90 per share against an estimate of $1.88, beating expectations by 1.06%. Upcoming reports are listed in the earnings calendar.

Zimmer Biomet Holdings, Inc. reported revenue of $2.06B in its most recent quarter, which has increased by 3.07% compared with the same quarter a year earlier. Analysts had expected $2.04B.

ZBH trades at a price-to-earnings ratio of 26.7 based on its earnings over the last twelve months.

Yes. Zimmer Biomet Holdings, Inc. pays dividends quarterly. The latest payment of $0.24 per share has a payment date of Oct 30, 2026, which corresponds to a dividend yield of 1.08%.

Companies most comparable to Zimmer Biomet Holdings, Inc. include Medtronic Plc, Stryker Corporation, Boston Scientific Corporation, Edwards Lifesciences Corporation and GE HealthCare Technologies Inc.

In the latest trading session ZBH moved between $105.70 and $111.20, a range of 5.19% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Zimmer Biomet Holdings, Inc. shows a strong buy rating today. Technical ratings are indicators, not investment advice.

Over the past 52 weeks ZBH has traded between $79.12 and $112.55. The current price is 5.77% below its 52-week high.